Indirect IL-4 pathway in type 1 immunity

被引:28
作者
Karulin, AY [1 ]
Hesse, MD [1 ]
Yip, HC [1 ]
Lehmann, PV [1 ]
机构
[1] Case Western Reserve Univ, Dept Pathol, Sch Med, Cleveland, OH 44106 USA
关键词
D O I
10.4049/jimmunol.168.2.545
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recall Ag-specific IL-4 was detected in the spleen and in the blood, but not in lymph nodes of mice in which polarized type 1 immunity was induced. This IL-4 was not produced by T cells, but soluble factors secreted by the recall Ag-activated T cells, including IL-3, triggered cells of the innate immune system, primarily mast cells, to secrete IL-4. This notion has profound implications for immunodiagnostics: the detection of apparently recall Ag-specific IL-4 does not necessarily reflect the presence of Th2 or Th0 memory T cells with long-term cytokine commitment as is of interest for assessing adoptive immunity. We found that in vivo the indirect IL-4 pathway did not suffice to trigger IgE isotype switching, but promoted IgG1 production and inhibited type 1 T cell differentiation. Therefore, the indirect IL-4 pathway can explain partial type 2 immune response phenotypes in vivo in face of unipolar Th1 T cell immunity. The representation of mast cells in different tissues may explain why immune responses in certain organs are more type 2 biased. Therefore, the indirect pathway of IL-4 production represents a novel type of interaction between the innate and the adoptive immune system that can contribute to the outcome of host defense and immune pathology.
引用
收藏
页码:545 / 553
页数:9
相关论文
共 56 条
[51]   Activation of Toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10 [J].
Thoma-Uszynski, S ;
Kiertscher, SM ;
Ochoa, MT ;
Bouis, DA ;
Norgard, MV ;
Miyake, K ;
Godowski, PJ ;
Roth, MD ;
Modlin, RL .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3804-3810
[52]  
TUOHY VK, 1989, J IMMUNOL, V142, P1523
[53]  
UMETSU DT, 1988, J IMMUNOL, V140, P4211
[54]   Response of naive and memory CD8+ T cells to antigen stimulation in vivo [J].
Veiga-Fernandes, H ;
Walter, U ;
Bourgeois, C ;
McLean, A ;
Rocha, B .
NATURE IMMUNOLOGY, 2000, 1 (01) :47-53
[55]  
Yip HC, 1999, J IMMUNOL, V162, P3942
[56]  
Zingoni A, 1998, J IMMUNOL, V161, P547